Recent legislation and new products have resulted in a number of new clinical service opportunities for pharmacists in community settings. These include providing naloxone to patients who may be at risk for opioid overdose and their family members; providing counseling, education and monitoring for patients taking specialty drugs (biologics); collaborative drug therapy management with physicians; and providing oral contraceptives without a prescription.
A big reason for these opportunities is the wide spread availability of community pharmacies. Community pharmacists are available in geographic areas and at times that physicians and other prescribers are not. And, consumers visit community pharmacies a lot more frequently than they visit other health care providers or sites. Continue reading